Get the Stockscreener App
5.89
1.51%
-0.09
After Hours:
6.01
0.12
+2.04%
Quanterix Corp stock is traded at $5.89, with a volume of 538.96K.
It is down -1.51% in the last 24 hours and down -19.97% over the past month.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
See More
Previous Close:
$5.98
Open:
$5.99
24h Volume:
538.96K
Relative Volume:
0.75
Market Cap:
$275.13M
Revenue:
$121.14M
Net Income/Loss:
$-32.33M
P/E Ratio:
-6.8488
EPS:
-0.86
Net Cash Flow:
$-22.69M
1W Performance:
+0.17%
1M Performance:
-19.97%
6M Performance:
+23.74%
1Y Performance:
-24.58%
1-Day Range:
$5.53
$6.15
1-Week Range:
$5.53
$6.38
52-Week Range:
$4.05
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
5.89 | 279.33M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test - MSN
Aug Swings: Should value investors consider Quanterix CorporationGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test - TradingView
Quanterix (QTRX) Submits Alzheimer's Blood Test for FDA Approval - GuruFocus
Quanterix submits FDA 510(k) for multi-analyte Alzheimer’s blood test - Investing.com
Blood test to spot Alzheimer’s earlier moves to FDA review - Stock Titan
Quanterix (NASDAQ:QTRX) Trading Down 3.6%Here's What Happened - MarketBeat
Quanterix (NASDAQ:QTRX) Trading Down 3.6% – Here’s What Happened - Defense World
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Study finds multi-biomarker approach improves Alzheimer’s risk assessment - Investing.com
15-year brain study: blood test combo better flags Alzheimer’s risk - Stock Titan
Quanterix Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
The Truth About Quanterix Corp (QTRX): Tiny Biotech, Massive Hype – But Is It Worth Your Money? - AD HOC NEWS
Big Money Moves: Is Quanterix Corporation stock overvalued by current metricsWeekly Trade Analysis & Community Consensus Trade Alerts - Bộ Nội Vụ
Does Quanterix Corporation stock benefit from AI growthWeekly Stock Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
Illumina names former NIH official as medical chief; commercial chief joins Quanterix - Seeking Alpha
Canaccord Genuity reiterates Hold rating on Quanterix stock By Investing.com - Investing.com Nigeria
Canaccord Genuity reiterates Hold rating on Quanterix stock - Investing.com
Why Quanterix Corporation stock could rally in 2025July 2025 Selloffs & Risk Controlled Daily Trade Plans - Улправда
How Quanterix Corporation stock compares to market leadersMarket Growth Report & Weekly Market Pulse Updates - Улправда
Quanterix (QTRX) Names Everett Cunningham as Upcoming CEO - GuruFocus
Can Quanterix Corporation stock continue upward trendTrade Exit Summary & Reliable Volume Spike Alerts - Улправда
Quanterix (QTRX) Appoints New CEO Amid Mixed Q3 Results - GuruFocus
Quanterix Corp Announces CEO Transition - TradingView — Track All Markets
Is Quanterix Corporation stock trading at a premium valuationJuly 2025 Rallies & Daily Volume Surge Signals - Улправда
Why Quanterix Corporation stock is seen as undervaluedJuly 2025 Update & Fast Momentum Stock Entry Tips - Улправда
Aug Outlook: How Quanterix Corporation stock trades before earnings2025 Investor Takeaways & Daily Profit Maximizing Tips - ulpravda.ru
Why Quanterix Corporation stock appeals to analystsRisk Management & Real-Time Stock Price Movement Reports - Улправда
Quanterix Corporation (NASDAQ:QTRX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Quanterix Corporation (NASDAQ:QTRX) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Quanterix Stock: Can This High-Beta Diagnostics Play Turn Volatility Into Long-Term Alpha? - AD HOC NEWS
Quanterix (NASDAQ:QTRX) Raised to Hold at Wall Street Zen - MarketBeat
Quanterix assay helps shed light on Alzheimer’s prevalence - BioWorld MedTech
QTRX FinancialsIncome Statement - Quiver Quantitative
Quanterix (QTRX) Analyst Rating Update: Price Target Raised by C - GuruFocus
Quanterix (NASDAQ:QTRX) Given New $8.00 Price Target at Canaccord Genuity Group - MarketBeat
Quanterix (QTRX) Study Sheds Light on Alzheimer's Prevalence - GuruFocus
Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence - Yahoo Finance
Quanterix (NASDAQ:QTRX) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Quanterix (NASDAQ:QTRX) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Is Quanterix Corporation stock attractive for income investorsPortfolio Gains Report & Real-Time Market Trend Scan - Улправда
Can Quanterix Corporation stock maintain growth trajectory2025 Breakouts & Breakdowns & Verified Short-Term Plans - Улправда
Alan Bruce Sachs Net Worth (2025) - GuruFocus
How sustainable is Quanterix Corporation stock dividend payoutPortfolio Update Report & Fast Exit/Entry Strategy Plans - DonanımHaber
Is Quanterix Corporation stock a top pick in earnings seasonWeekly Trend Recap & Weekly High Potential Stock Alerts - Улправда
Momentum Shift: Why Quanterix Corporation stock attracts high net worth investorsJuly 2025 Trends & Verified Swing Trading Watchlists - Улправда
Why Quanterix Corporation stock attracts high net worth investorsJuly 2025 Earnings & Safe Capital Allocation Plans - Улправда
CFO Sriram Acquires 548 Of Quanterix Corp [QTRX] - TradingView — Track All Markets
CEO Toloue Acquires 2,480 Of Quanterix Corp [QTRX] - TradingView — Track All Markets
Quanterix (QTRX) Projected to Post Earnings on Monday - MarketBeat
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):